Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acquired Immunodeficiency Syndrome × Mammography × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 49 Disease 5 Obesity 2 Carcinoma, Intraductal, Noninfiltrating 2 Women With Breast Cancer 1 Prostatic Neoplasms 1 Obesity, Morbid 1 Neoplasms 1 Mammary Neoplasms, Animal 1 Hypersensitivity 1 Fibrocystic Breast Disease 1 Digital Breast Tomosynthesis 1 Cysts 1 Colorectal Neoplasms 1 Breast Screening 1 Breast Cancer Screening 1 Breast Cancer Detection 1 Asymptomatic 1 Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 16 Vincristine 12 Zidovudine 11 Bleomycin 11 Interferon alpha-2 6 Cyclophosphamide 6 Methotrexate 5 Liposomes 5 Leucovorin 5 Dexamethasone 5 sargramostim 4 Filgrastim 4 Etoposide 4 Cytarabine 4 tecogalan 3 Ritonavir 3 Nivolumab 3 Fluorouracil 3 pomalidomide 2 liposomal doxorubicin 2 interferon alfa-n1 2 Valganciclovir 2 Tumor Necrosis Factor-alpha 2 Thalidomide 2 Rituximab 2 Paclitaxel 2 Observation 2 Maraviroc 2 Isotretinoin 2 Interviews as Topic 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04735445 2021-02-03

IMPACNEO

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Phase NA Unknown

Acquired Immunodeficiency Syndrome, Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡